Hypothalamic-pituitary-adrenal Axis Dysfunction in Critically Ill Foals and Horses.

Overview

• This research article explores dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis in critically ill foals and horses, specifically focusing on critical illness-related corticosteroid insufficiency (CIRCI).
• The study highlights the challenges in diagnosing CIRCI and discusses emerging testing methods that could improve diagnosis and treatment outcomes through more tailored steroid replacement therapy.

Introduction to HPA Axis Dysfunction in Equine Critical Illness

• The hypothalamic-pituitary-adrenal (HPA) axis is a critical hormonal system that regulates the stress response, primarily through the production and release of cortisol.
• In critical illnesses such as endotoxemia and sepsis, the HPA axis should ideally respond by elevating cortisol levels to help manage stress and inflammation.
• However, in some critically ill foals and horses, this axis becomes transiently dysfunctional, a state termed critical illness-related corticosteroid insufficiency (CIRCI).
• CIRCI results in insufficient cortisol production relative to the severity of stress, compromising the animal’s ability to cope with critical illness.

Clinical Significance of CIRCI in Foals and Horses

• CIRCI is associated with poorer clinical outcomes including increased morbidity and mortality in affected animals.
• The condition can exacerbate systemic inflammation, leading to more severe manifestations of infection and inflammation in foals and horses.
• Recognizing CIRCI is important because it may influence the therapeutic approach, particularly the use of corticosteroid replacement therapy.

Challenges in Diagnosing CIRCI

• Diagnosis is complex due to significant interindividual variability in cortisol responses among critically ill horses and foals.
• Baseline cortisol levels alone may be insufficient to detect CIRCI accurately because some animals may have normal or high cortisol levels despite insufficient stress response.
• Dynamic testing, involving stimulation or suppression of the HPA axis and subsequent hormone measurement, is required for more accurate diagnosis.
• The stress caused by critical illness complicates interpretation because hormonal levels fluctuate and may vary with timing and illness severity.

Recent Advances in Assessment Techniques

• Dynamic adrenal function tests, such as the adrenocorticotropic hormone (ACTH) stimulation test, have been developed to assess the functional capacity of the HPA axis.
• Point-of-care hormone assays for cortisol measurement enable faster and more practical hormone level assessments during critical illness.
• These new testing modalities could enhance clinicians’ ability to identify CIRCI promptly and accurately.
• Improved diagnosis supports more personalized therapeutic interventions, such as targeted corticosteroid supplementation only in animals with confirmed insufficiency.

Implications for Treatment and Future Directions

• Understanding and detecting CIRCI allows for consideration of corticosteroid replacement therapy, which may improve hemodynamic stability and outcomes.
• However, indiscriminate steroid use may lead to adverse effects, thus emphasizing the need for precise diagnosis.
• Future research aims to refine diagnostic criteria, validate point-of-care tests, and optimize steroid dosing regimens specific to equine patients.
• Overall, advances in diagnosing and managing HPA axis dysfunction have the potential to improve survival rates and quality of care in critically ill foals and horses.